Tissue engineering of blood vessels in cardiovascular disease: Moving towards clinical translation

Heart

Volumn 99, Issue 7, 2013, Pages 454-460

  Udelsman, Brooks V ^a   Maxfield, Mark W ^a   Breuer, Christopher K ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOTECHNOLOGY; BLOOD VESSEL GRAFT; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL SUSPENSION; CLINICAL TRIAL (TOPIC); CONGENITAL HEART DISEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL; HUMAN; MACROPHAGE; MONONUCLEAR CELL; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING;

ANIMALS; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIOVASCULAR DISEASES; FORECASTING; HUMANS; PROSTHESIS DESIGN; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84875231374     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302984     Document Type: Article

References (36)

1. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-6. (Pubitemid 23209960)
2. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986;231:397-400. (Pubitemid 16108649)
3. Shinoka T, Shum-Tim D, Ma PX, et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998;115:536-45; discussion 45-6.
4. Naito Y, Imai Y, Shin'oka T, et al. Successful clinical application of tissue-engineered graft for extracardiac Fontan operation. J Thorac Cardiovasc Surg 2003;125:419-20. (Pubitemid 36228326)
5. Hibino N, McGillicuddy E, Matsumura G, et al. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 2010;139:431-6, 6 e1-2.
6. Watanabe M, Shin'oka T, Tohyama S, et al. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng 2001;7:429-39. (Pubitemid 32734775)
7. Shin'oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001;344:532-3.
8. Giannico S, Hammad F, Amodeo A, et al. Clinical outcome of 193 extracardiac Fontan patients: the first 15 years. J Am Coll Cardiol 2006;47:2065-73.
9. Kim SJ, Kim WH, Lim HG, et al. Outcome of 200 patients after an extracardiac Fontan procedure. J Thorac Cardiovasc Surg 2008;136:108-16.
10. Nakano T, Kado H, Tachibana T, et al. Excellent midterm outcome of extracardiac conduit total cavopulmonary connection: results of 126 cases. Ann Thorac Surg 2007;84:1619-25; discussion 25-6.
11. Brennan MP, Dardik A, Hibino N, et al. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg 2008;248:370-7.
12. Roh JD, Nelson GN, Brennan MP, et al. Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Biomaterials 2008;29:1454-63.
13. Roh JD, Sawh-Martinez R, Brennan MP, et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A 2010;107:4669-74.
14. Voskuil M, van Royen N, Hoefer IE, et al. Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am J Physiol Heart Circ Physiol 2003;284:H1422-8. (Pubitemid 36348606)
15. Mirensky TL, Hibino N, Sawh-Martinez RF, et al. Tissue-engineered vascular grafts: does cell seeding matter? J Pediatr Surg 2010;45:1299-305.
16. Harrington JK, Chahboune H, Criscione JM, et al. Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI. FASEB J 2011;25:4150-61.
17. Hibino N, Villalona G, Pietris N, et al. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. FASEB J 2011;25:2731-9.
18. Naito Y, Williams-Fritze M, Duncan DR, et al. Characterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation. Cells Tissues Organs 2012;195:60-72.
19. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007;8:221-33.
20. Bendeck MP, Zempo N, Clowes AW, et al. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 1994;75:539-45. (Pubitemid 24256415)
21. Godin D, Ivan E, Johnson C, et al. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation 2000;102:2861-6.
22. Hibino N, Yi T, Duncan DR, et al. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J 2011;25:4253-63.
23. Duncan DR, Breuer CK. Challenges in translating vascular tissue engineering to the pediatric clinic. Vascular cell 2011;3:23.
24. Pera MF. Stem cells: the dark side of induced pluripotency. Nature 2011;471:46-7.
25. Zhao T, Zhang ZN, Rong Z, et al. Immunogenicity of induced pluripotent stem cells. Nature 2011;474:212-15.
26. Kakisis JD, Liapis CD, Breuer C, et al. Artificial blood vessel: the Holy Grail of peripheral vascular surgery. J Vasc Surg 2005;41:349-54. (Pubitemid 40342491)
27. Conte MS. The ideal small arterial substitute: a search for the Holy Grail? FASEB J 1998;12:43-5.
28. Udelsman B, Hibino N, Villalona GA, et al. Development of an operatorindependent method for seeding tissue-engineered vascular grafts. Tissue Eng Part C, Methods 2011;17:731-6.
29. Hibino N, Nalbandian A, Devine L, et al. Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method. Tissue Eng Part C, Methods 2011;17:993-8.
30. Thorat C, Xu K, Freeman SN, et al. What the Orphan Drug Act has done lately for children with rare diseases: a 10-year analysis. Pediatrics 2012;129: 516-21.
31. Mirensky TL, Nelson GN, Brennan MP, et al. Tissue-engineered arterial grafts: long-term results after implantation in a small animal model. J Pediatr Surg 2009;44:1127-32; discussion 32-3.
32. de Valence S, Tille JC, Mugnai D, et al. Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model. Biomaterials 2012;33:38-47.
33. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997;28:5-24. (Pubitemid 27497671)
34. Wu W, Allen RA, Wang Y. Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery. Nat Med 2012;18:1148-53.
35. Gleason RL, Gray SP, Wilson E, et al. A multiaxial computer-controlled organ culture and biomechanical device for mouse carotid arteries. J Biomech Eng 2004;126:787-95. (Pubitemid 40293727)
36. Niklason LE, Yeh AT, Calle EA, et al. Enabling tools for engineering collagenous tissues integrating bioreactors, intravital imaging, and biomechanical modeling. Proc Natl Acad Sci U S A 2010;107:3335-9.